AC Immune SA Statistics
NASDAQ: ACIUHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.57+0.05 (+1.98%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
AC Immune SA by the numbers
AC Immune SA has a market capitalization of $255.5 million based on 99.43M shares outstanding. With trailing EPS of $-0.55, AC Immune SA is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 1.6% below its 50-day average and 8.5% below its 200-day average.
Average daily trading volume is 204.00K shares, or about $524,275 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ACIU valuation vs. peer median
| Metric | ACIU | Peer median | Difference |
|---|---|---|---|
| Market cap | $255.53M | $249.97M | +2% |
| Avg. volume | 204.00K | 497.54K | -59% |
Peer median across 8 companies: AMRN, UPB, BCYC, ZNTL, IMRX, LFCR, VCRE, AKBA.
Valuation
- Market cap
- $255.53M
- Forward P/E
- 4.32
- EPS (TTM)
- $-0.55
- Shares outstanding
- 99.43M
Price and trading
- Previous close
- 2.52
- Open
- 2.52
- Day range
- 2.51 – 2.59
- 52-week range
- 2.10 – 4.00
- 52-week change
- -28.41%
- Beta
- —
- Volume
- 125.05K
- Average volume
- 204.00K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 255.53M
- Forward Pe
- 4.32
- Eps
- -0.55
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 4.00
- Week52 Low
- 2.10
- Avg Volume
- 204.00K
- Shares Outstanding
- 99.43M
- Ma50
- 2.61
- Ma200
- 2.81
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -35.75%
- Pct From52w Low
- 22.67%